Guidelines for palliative surgery of cholangiocarcinoma

ανά Witzigmann, H., Lang, H., Lauer, H.
Έκδοση 2008

An unusual cause and treatment for ascites after liver transplantation

ανά Feisthammel, J, Troltzsch, M, Witzigmann, H, Mossner, J, Caca, K
Έκδοση 2006

Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

ανά Halm, U, Schumann, T, Schiefke, I, Witzigmann, H, Mössner, J, Keim, V
Έκδοση 2000

INK4a-ARF alterations in liver cell adenoma

ανά Tannapfel, A, Busse, C, Geiβler, F, Witzigmann, H, Hauss, J, Wittekind, C
Έκδοση 2002

INK4a-ARF alterations in liver cell adenoma

ανά Tannapfel, A, Busse, C, Geiβler, F, Witzigmann, H, Hauss, J, Wittekind, C
Έκδοση 2002

Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma

ανά Tannapfel, A, Sommerer, F, Benicke, M, Katalinic, A, Uhlmann, D, Witzigmann, H, Hauss, J, Wittekind, C
Έκδοση 2003

Heparanase is a prognostic indicator for postoperative survival in pancreatic carcinoma

ανά Rohloff, J, Zinke, J, Schoppmeyer, K, Tannapfel, A, Witzigmann, H, Mössner, J, Wittekind, C, Caca, K
Έκδοση 2002

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

ανά Rohloff, J, Zinke, J, Schoppmeyer, K, Tannapfel, A, Witzigmann, H, Mössner, J, Wittekind, C, Caca, K
Έκδοση 2002